The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-2-(4'-tert-butylbiphenyl-2-ylcarboxamido)-N-(2-(4-fluorobenzylamino)-2-oxo-1-phenylethyl)quinoline-6-carboxamide ID: ALA2147297
Chembl Id: CHEMBL2147297
PubChem CID: 15603841
Max Phase: Preclinical
Molecular Formula: C42H37FN4O3
Molecular Weight: 664.78
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)(C)c1ccc(-c2ccccc2C(=O)Nc2ccc3cc(C(=O)N[C@H](C(=O)NCc4ccc(F)cc4)c4ccccc4)ccc3n2)cc1
Standard InChI: InChI=1S/C42H37FN4O3/c1-42(2,3)32-19-15-28(16-20-32)34-11-7-8-12-35(34)40(49)46-37-24-18-30-25-31(17-23-36(30)45-37)39(48)47-38(29-9-5-4-6-10-29)41(50)44-26-27-13-21-33(43)22-14-27/h4-25,38H,26H2,1-3H3,(H,44,50)(H,47,48)(H,45,46,49)/t38-/m0/s1
Standard InChI Key: PKHKBSZSOWOOPU-LHEWISCISA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 664.78Molecular Weight (Monoisotopic): 664.2850AlogP: 8.38#Rotatable Bonds: 9Polar Surface Area: 100.19Molecular Species: NEUTRALHBA: 4HBD: 3#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): 2CX Acidic pKa: 13.66CX Basic pKa: 1.68CX LogP: 8.78CX LogD: 8.78Aromatic Rings: 6Heavy Atoms: 50QED Weighted: 0.14Np Likeness Score: -1.31
References 1. Robinson RP, Bartlett JA, Bertinato P, Bessire AJ, Cosgrove J, Foley PM, Manion TB, Minich ML, Ramos B, Reese MR, Schmahai TJ, Swick AG, Tess DA, Vaz A, Wolford A.. (2011) Discovery of microsomal triglyceride transfer protein (MTP) inhibitors with potential for decreased active metabolite load compared to dirlotapide., 21 (14): [PMID:21684740 ] [10.1016/j.bmcl.2011.05.099 ]